SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Myriad Genetics, Inc. (MYGN)
An SI Board Since August 1996
Posts SubjectMarks Bans Symbol
2355 65 0 MYGN
Emcee:  s myers Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
2105Citi: 21 May 2008 ? 7 pages Myriad Genetics Inc (MYGN) Flurizan Strikes a Deal mopgcw-5/23/2008
2104If the drug fails, partnership will end and the money will flow into income on cRobohogs-5/22/2008
2103Funny but stock went up exactly by the amount of the new money, give or take. IRobohogs-5/22/2008
2102<i>Why so? Tax planning?</i> Standard GAAP treatment for such an upDewDiligence_on_SI-5/22/2008
2101here's the party line..... Curr Top Med Chem. 2008;8(1):54-61. Therapeuticscaram(o)uche-5/22/2008
2100They've got the correct patient population targeted, it's a big trial. scaram(o)uche-5/22/2008
2099Love this stuff. Don't have any mygn, but enjoy following the bouncing ballfred hayes-5/22/2008
2098<i> You'll remember that the original "phase III" looked notA.J. Mullen-5/22/2008
2097">>Can flurbie be approved for more than one indication? << Istuck-5/22/2008
2096>> Until trials for the severe are failed << Message 21284432 You&scaram(o)uche-5/22/2008
2095<i>Can flurbie be approved for more than one indication? </i> Is thA.J. Mullen-5/22/2008
2094Let's face it, every pharma/biotech deal is in reality just a call option. Vrkrw-5/22/2008
2093Well, OK. Can flurbie be approved for more than one indication? Mild to moderattuck-5/22/2008
2092PR said royalty rates 20-39%, less cogs. <<Furthermore, Lundbeck has agrrkrw-5/22/2008
2091>>Either they are valuing the potential highly or the probability of succetuck-5/22/2008
2090I thought it was 1 in 3 to 1 in 5 myself. They would have been better off buyinRobohogs-5/22/2008
2089I don't know. Would $500 million be too much if it were approved? MAybe noA.J. Mullen-5/22/2008
2088Ya, expected a little more bump here. However they account for it, it's cashfred hayes-5/22/2008
2087<i> Meldrum said Myriad will recognize the initial $100 million payment frA.J. Mullen-5/22/2008
2086"The initial $100 million payment will be made regardless of whether the pefred hayes-5/22/2008
2085May 22, 2008 06:30 ET Myriad Genetics Selects Lundbeck as European Partner for Fsim1-5/22/2008
2084Utah-developed drug gets E.U. marketer By Steven Oberbeck The Salt Lake Tribune sim1-5/22/2008
2083Genetic link to prostate cancer Canberra Times - May. 20, 2008 A genetic malfusim1-5/20/2008
2082citi: Myriad Genetics Inc (MYGN) Preview of Upcoming Binary Event; Option Stratemopgcw-5/14/2008
2081sometimes people really dont think things through before they speak...I agree itmopgcw-5/14/2008
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News